{"id":"W2981492072","doi":"10.1016/j.tmrv.2019.09.004","title":"Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics","year":2019,"lang":"en","type":"review","venue":"Transfusion Medicine Reviews","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Atypical hemolytic uremic syndrome; Complement system; Anaphylatoxin; Complement component 5; Complement (music); Monoclonal antibody; Immunology; Antibody; Biology; Phenotype","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009120687,0.0005195472,0.003045017,0.00012512,0.0001401899,0.000006448165,0.0004016228,0.0002137654,0.001343476],"category_scores_gemma":[0.000006480107,0.000242773,0.0003286728,0.0001875106,0.0003938636,0.00002612439,0.0001174544,0.0003856429,0.0000537456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000214685,"about_ca_system_score_gemma":0.00005942956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006501324,"about_ca_topic_score_gemma":0.00001685657,"domain_scores_codex":[0.9963582,0.001369557,0.001432596,0.0004616718,0.0001075536,0.0002703948],"domain_scores_gemma":[0.9980114,0.0004872737,0.000649885,0.000763715,0.00005001003,0.00003771223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000124976,0.00003736721,0.00003098628,0.03206408,0.0002980217,7.066251e-7,0.000339989,4.283823e-9,0.00002518352,0.0003463112,0.0277815,0.9390634],"study_design_scores_gemma":[0.0008999959,0.0002576874,0.00002972577,0.0104813,0.003985493,0.0001048164,0.0002523416,1.873359e-7,0.000001021486,0.00002059148,0.9837627,0.0002041694],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000133393,0.9914395,0.00002601312,0.002042877,0.0007765112,0.004895259,0.0001195297,0.00001750899,0.0006694834],"genre_scores_gemma":[0.000002405934,0.9983022,0.00001507444,0.0002243154,0.0005628373,0.0001809438,0.0003287038,0.00003178975,0.0003517061],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9559812,"threshold_uncertainty_score":0.9995694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09839275555475246,"score_gpt":0.370758888813389,"score_spread":0.2723661332586365,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}